Patients with previously treated advanced KRAS G12C-mutant non-small cell lung cancer (NSCLC) lived significantly longer and saw improved disease control when treated with the next-generation KRAS-targeted therapy divarasib, ...
22 hours ago
0
5
Weightlifting has a reputation for "bulking up," so it may not be the first type of exercise you choose when you want to lose weight.
20 hours ago
0
29
Patients have been left feeling suicidal after feeling like their doctor was saying their symptoms were 'all in their head'—according to research from the University of East Anglia and the University of Cambridge.
18 hours ago
0
5
The American Heart Association, American Academy of Pediatrics, American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine have released a publication that redefines heart health in girls ...
21 hours ago
0
10
Feeling overwhelmed by the noise and chaos of parenting? You're not alone.
20 hours ago
0
6
Research led by internist-nephrologist Dr. Michele Eisenga shows that SGLT2 inhibitors, a class of drugs widely used to treat type 2 diabetes, heart failure and chronic kidney disease, consistently increase hemoglobin and ...
21 hours ago
0
8
When it comes to blood clots, it is not only how they form that is crucial, but also how the body can break them down again. A team of researchers at the University of Koblenz, led by Prof. Dr. Marie-T. Hopp, has demonstrated ...
18 hours ago
0
2
Conversational AI chatbots are a relatively new technology, but they are now ubiquitous, embedded in everything from customer service platforms to personal productivity tools. Such is their rapid adoption that potential negative ...
Long COVID is often associated with symptoms such as persistent fatigue, shortness of breath and brain fog. But evidence increasingly shows that long COVID may have a broad effect on the cardiovascular system, as well.
23 hours ago
0
8
Adding a personalized mRNA-based cancer vaccine to immunotherapy after surgery for high-risk melanoma reduced the risk of recurrence or death by 42%, according to results from the phase 3 INTerpath-001 trial presented at ...
21 hours ago
0
4
